Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.6.0.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Consolidated Statements of Operations [Abstract]    
Sales $ 6,414,800 $ 139,980
Cost of Sales 13,578,262
Gross loss (7,163,462) 139,980
Operating Expenses    
Selling, general and administrative 6,202,569 3,860,618
Research and development 6,145,801 4,740,331
Total operating expenses 12,348,370 8,600,949
Interest expense, net 44,036 965,884
Net loss $ (19,555,868) $ (9,426,853)
Basic and diluted loss per share $ (0.78) $ (0.55)
Weighted average number of common shares outstanding 25,201,261 17,293,394